 | • レポートコード：MRC23Q36058 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血液学コントロール＆キャリブレーター市場について調査・分析し、世界の血液学コントロール＆キャリブレーター市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（3分割、5分割、その他）、用途別セグメント分析（病院、独立研究室、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatronなどが含まれています。世界の血液学コントロール＆キャリブレーター市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血液学コントロール＆キャリブレーター市場規模を推定する際に考慮しました。本レポートは、血液学コントロール＆キャリブレーターの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血液学コントロール＆キャリブレーターに関するビジネス上の意思決定に役立てることを目的としています。 ・血液学コントロール＆キャリブレーター市場の概要 - 血液学コントロール＆キャリブレーターのタイプ別セグメント - 世界の血液学コントロール＆キャリブレーター市場規模：タイプ別分析（3分割、5分割、その他） - 血液学コントロール＆キャリブレーターの用途別セグメント - 世界の血液学コントロール＆キャリブレーター市場規模：用途別分析（病院、独立研究室、その他） - 世界の血液学コントロール＆キャリブレーター市場規模予測（2018年-2029年） ・血液学コントロール＆キャリブレーター市場の成長トレンド - 血液学コントロール＆キャリブレーターの地域別市場規模（2018年-2029年） - 血液学コントロール＆キャリブレーター市場ダイナミクス - 血液学コントロール＆キャリブレーターの業界動向 - 血液学コントロール＆キャリブレーター市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：3分割、5分割、その他 - 世界の血液学コントロール＆キャリブレーターのタイプ別市場規模（2018年-2023年） - 世界の血液学コントロール＆キャリブレーターのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、独立研究室、その他 - 世界の血液学コントロール＆キャリブレーターの用途別市場規模（2018年-2023年） - 世界の血液学コントロール＆キャリブレーターの用途別市場規模（2024年-2029年） ・血液学コントロール＆キャリブレーターの地域別市場規模 - 北米の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - アメリカの血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - ヨーロッパの血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - アジア太平洋の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - 中国の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - 日本の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - 韓国の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - インドの血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - オーストラリアの血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - 中南米の血液学コントロール＆キャリブレーター市場規模（2018年-2029年） - 中東・アフリカの血液学コントロール＆キャリブレーター市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatron ・アナリストの観点/結論 ・調査方法とデータソース |
Hematology controls are used to assess the precision of instruments such as hematology analyzers, thereby ensuring valid patient results and fulfilling accreditation requirements. The controls are commonly found in the clinical diagnostics laboratory.
Highlights
The global Hematology Controls and Calibrator market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Hematology Controls and Calibrator is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Hematology Controls and Calibrator is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Hematology Controls and Calibrator in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Hematology Controls and Calibrator include Sysmex, Danaher, Bio-Rad, Mindray, Abbott, Horiba, Boule and Diatron, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematology Controls and Calibrator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Controls and Calibrator.
The Hematology Controls and Calibrator market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hematology Controls and Calibrator market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Controls and Calibrator companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron
Segment by Type
3-Part
5-Part
Other
Segment by Application
Hospital
Independent Lab
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Controls and Calibrator companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematology Controls and Calibrator Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 3-Part
1.2.3 5-Part
1.2.4 Other
1.3 Market by Application
1.3.1 Global Hematology Controls and Calibrator Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Independent Lab
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematology Controls and Calibrator Market Perspective (2018-2029)
2.2 Hematology Controls and Calibrator Growth Trends by Region
2.2.1 Global Hematology Controls and Calibrator Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hematology Controls and Calibrator Historic Market Size by Region (2018-2023)
2.2.3 Hematology Controls and Calibrator Forecasted Market Size by Region (2024-2029)
2.3 Hematology Controls and Calibrator Market Dynamics
2.3.1 Hematology Controls and Calibrator Industry Trends
2.3.2 Hematology Controls and Calibrator Market Drivers
2.3.3 Hematology Controls and Calibrator Market Challenges
2.3.4 Hematology Controls and Calibrator Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematology Controls and Calibrator Players by Revenue
3.1.1 Global Top Hematology Controls and Calibrator Players by Revenue (2018-2023)
3.1.2 Global Hematology Controls and Calibrator Revenue Market Share by Players (2018-2023)
3.2 Global Hematology Controls and Calibrator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematology Controls and Calibrator Revenue
3.4 Global Hematology Controls and Calibrator Market Concentration Ratio
3.4.1 Global Hematology Controls and Calibrator Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematology Controls and Calibrator Revenue in 2022
3.5 Hematology Controls and Calibrator Key Players Head office and Area Served
3.6 Key Players Hematology Controls and Calibrator Product Solution and Service
3.7 Date of Enter into Hematology Controls and Calibrator Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematology Controls and Calibrator Breakdown Data by Type
4.1 Global Hematology Controls and Calibrator Historic Market Size by Type (2018-2023)
4.2 Global Hematology Controls and Calibrator Forecasted Market Size by Type (2024-2029)
5 Hematology Controls and Calibrator Breakdown Data by Application
5.1 Global Hematology Controls and Calibrator Historic Market Size by Application (2018-2023)
5.2 Global Hematology Controls and Calibrator Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hematology Controls and Calibrator Market Size (2018-2029)
6.2 North America Hematology Controls and Calibrator Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hematology Controls and Calibrator Market Size by Country (2018-2023)
6.4 North America Hematology Controls and Calibrator Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematology Controls and Calibrator Market Size (2018-2029)
7.2 Europe Hematology Controls and Calibrator Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hematology Controls and Calibrator Market Size by Country (2018-2023)
7.4 Europe Hematology Controls and Calibrator Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematology Controls and Calibrator Market Size (2018-2029)
8.2 Asia-Pacific Hematology Controls and Calibrator Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hematology Controls and Calibrator Market Size by Region (2018-2023)
8.4 Asia-Pacific Hematology Controls and Calibrator Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematology Controls and Calibrator Market Size (2018-2029)
9.2 Latin America Hematology Controls and Calibrator Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hematology Controls and Calibrator Market Size by Country (2018-2023)
9.4 Latin America Hematology Controls and Calibrator Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematology Controls and Calibrator Market Size (2018-2029)
10.2 Middle East & Africa Hematology Controls and Calibrator Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hematology Controls and Calibrator Market Size by Country (2018-2023)
10.4 Middle East & Africa Hematology Controls and Calibrator Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sysmex
11.1.1 Sysmex Company Detail
11.1.2 Sysmex Business Overview
11.1.3 Sysmex Hematology Controls and Calibrator Introduction
11.1.4 Sysmex Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.1.5 Sysmex Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Hematology Controls and Calibrator Introduction
11.2.4 Danaher Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.2.5 Danaher Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Hematology Controls and Calibrator Introduction
11.3.4 Bio-Rad Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 Mindray
11.4.1 Mindray Company Detail
11.4.2 Mindray Business Overview
11.4.3 Mindray Hematology Controls and Calibrator Introduction
11.4.4 Mindray Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.4.5 Mindray Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Hematology Controls and Calibrator Introduction
11.5.4 Abbott Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Horiba
11.6.1 Horiba Company Detail
11.6.2 Horiba Business Overview
11.6.3 Horiba Hematology Controls and Calibrator Introduction
11.6.4 Horiba Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.6.5 Horiba Recent Development
11.7 Boule
11.7.1 Boule Company Detail
11.7.2 Boule Business Overview
11.7.3 Boule Hematology Controls and Calibrator Introduction
11.7.4 Boule Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.7.5 Boule Recent Development
11.8 Diatron
11.8.1 Diatron Company Detail
11.8.2 Diatron Business Overview
11.8.3 Diatron Hematology Controls and Calibrator Introduction
11.8.4 Diatron Revenue in Hematology Controls and Calibrator Business (2018-2023)
11.8.5 Diatron Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details